Rimonabant Accepted for Filing By the FDA
PARIS, June 23, 2005 — Sanofi-aventis announced today that the United States Food and Drug Administration (FDA) has accepted for filing the company’s New Drug Application (NDA) for rimonabant, the first agent in a …